Merve Keskinkilic | Medical Oncology | Best Researcher Award

Posted on by ScienceFather

Dr. Merve Keskinkilic | Medical Oncology | Best Researcher Award

Medical Oncologist, Izmir Democracy University Buca Seyfi Demirsoy Training and Research Hospital Turkey

Merve Keskinkılıç is a dedicated Medical Oncologist at Burdur State Hospital with a strong academic background in Internal Medicine and Medical Oncology. She earned her M.D. from Dokuz Eylul University Faculty of Medicine and completed her Medical Oncology Fellowship at the same institution. Dr. Keskinkılıç has extensive clinical experience, having served as a Research Fellow at Emory University, USA. Fluent in English (C1 Advanced) and proficient in German (Elementary), she actively participates in international oncology research. Her expertise includes clinical trials, cancer treatment strategies, and translational oncology research, contributing significantly to advancements in the field.

Publication Profile

Scopus

Scholar

🎓 Education

Dr. Keskinkılıç completed her high school education at Balıkesir Science High School (2004-2008) before pursuing medicine at Dokuz Eylul University (2008-2014). She participated in an Oncology Exchange Program at Mansoura University, Egypt (2010). She later obtained an Associate Degree in Healthcare Management from Anadolu University (2014-2017). Her residency in Internal Medicine was completed at Celal Bayar University (2015-2016) and Dokuz Eylul University (2016-2019). She pursued a Medical Oncology Fellowship at Dokuz Eylul University (2019-2024) and is currently undertaking a PhD in Basic Oncology at Dokuz Eylul University Oncology Institute (since 2022). She also worked as a Research Fellow at Emory University, USA (2023).

💼 Experience

Dr. Keskinkılıç began her career as a General Practitioner at Balıkesir Susurluk State Hospital (2014-2015) before becoming a Research Assistant in Internal Medicine at Celal Bayar University (2015-2016) and later at Dokuz Eylul University (2016-2019). She served as a Specialist Doctor at Bitlis Mutki State Hospital (2019) and as a Fellow in Medical Oncology at Dokuz Eylul University (2019-2024). Currently, she is a Medical Oncologist at Burdur Public Hospital (2024-2025) and will join Izmir Democracy University Buca Seyfi Demirsoy Training and Research Hospital in 2025.

🏆 Awards & Honors

Dr. Keskinkılıç holds several prestigious certifications, including the Turkish Board of Internal Medicine Certificate (2018), Experimental Animal Use Certificate (2019), Oncology Clinical Research Training Certificate (2020), and ESMO Board of Examination Certificate (2023). She has also completed Good Clinical Practices (ICU) and Clinical Research Training and has received certifications in Research Ethics and Clinical Trials. Her contributions to oncology research and education have been recognized through multiple national and international accolades.

🔬 Research Focus

Dr. Keskinkılıç specializes in clinical oncology research, focusing on urothelial, bladder, gastric, prostate, and lung cancers. She is actively involved in multiple clinical trials, serving as a Sub-Investigator in research projects such as THOR (Urothelial Cancer), Niagara (Bladder Cancer), MK3475-859 (Gastric Cancer), Regeneron (Non-Small Cell Lung Cancer), and Radiant 20510 (Prostate Cancer). Her work emphasizes innovative treatment strategies, immunotherapy, and targeted cancer therapies, contributing to the development of advanced oncological treatments. Her internal medicine dissertation evaluated CMV DNA Antigenemia in Allogeneic Bone Marrow Transplant Patients.

Publication Top Notes

  • Efficacy of subsequent treatments in patients with hormone-positive advanced breast cancer who had disease progression under CDK 4/6 inhibitor therapy
    • Authors: C. Karacin, B. Oksuzoglu, A. Demirci, M. Keskinkılıç, et al.
    • Journal: BMC Cancer, 2023
    • Citations: 20

 

  • Treatment efficacy of ribociclib or palbociclib plus letrozole in hormone receptor-positive/HER2-negative metastatic breast cancer
    • Authors: S. Kahraman, E. Erul, M. Seyyar, O. Gumusay, et al.
    • Journal: Future Oncology, 2023
    • Citations: 13

 

  • Clinical outcomes of cyclin-dependent kinase 4–6 (CDK 4–6) inhibitors in patients with male breast cancer: a multicenter study
    • Authors: H. Ç. Yıldırım, E. Mutlu, E. Chalabiyev, M. Özen, et al.
    • Journal: The Breast, 2022
    • Citations: 13

 

  • The effect of low HER2 expression on treatment outcomes in metastatic hormone receptor-positive breast cancer patients treated with a combination of a CDK4/6 inhibitor and…
    • Authors: E. C. Yildirim, E. Atag, E. Coban, et al.
    • Journal: The Breast, 2023
    • Citations: 12

 

  • Efficacy of first-line CDK 4-6 inhibitors in premenopausal patients with metastatic breast cancer and the effect of dose reduction due to treatment-related neutropenia
    • Authors: H. C. Yildirim, C. Kapar, B. Koksal, et al.
    • Journal: Journal of Chemotherapy, 2024
    • Citations: 4

 

  • The prognostic indicator in breast cancer treated with CDK4/6 inhibitors: the prognostic nutritional index
    • Authors: M. Keskinkilic, H. S. Semiz, G. Polat, et al.
    • Journal: Future Oncology, 2023
    • Citations: 4

 

  • Antibody-Drug Conjugates in Triple Negative Breast Cancer
    • Authors: M. Keskinkilic, R. Sacks
    • Journal: Clinical Breast Cancer, 2024
    • Citations: 3

 

  • 194P Increased blood creatinine level due to CDK 4/6 inhibitor treatments: single center experience
    • Authors: M. Keskinkılıç, H. S. Semiz, T. Yavuzsen, A. Karaoglu
    • Journal: Annals of Oncology, 2022
    • Citations: 3

 

  • The prognostic nutritional index (PNI): A new biomarker for determining prognosis in metastatic castration-sensitive prostate carcinoma
    • Authors: H. I. Ellez, M. Keskinkilic, et al.
    • Journal: Journal of Clinical Medicine, 2023
    • Citations: 11

 

  • The role of immune checkpoint inhibition in triple-negative breast cancer
    • Authors: K. Tarekegn, M. Keskinkilic, T. J. Kristoff, S. T. Evans, K. Kalinsky
    • Journal: Expert Review of Anticancer Therapy, 2023
    • Citations: 10

 

  • The percentage of ALK-positive cells and the efficacy of first-line alectinib in advanced non-small cell lung cancer
    • Authors: M. Hizal, B. Bilgin, N. Paksoy, et al.
    • Journal: Journal of Cancer Research and Clinical Oncology, 2023
    • Citations: 5

 

  • CD47 (‘don’t eat me’ signal) expression levels and its relationship with clinicopathologic features in early‐stage prostate carcinoma
    • Authors: H. S. Semiz, Ü. Küçük, E. Kısa, M. Keskinkılıç, et al.
    • Journal: The Prostate, 2022
    • Citations: 5

 

  • A severe case of levothyroxine intoxication successfully treated in intensive care unit
    • Authors: Y. Savran, T. Mengi, M. Keskinkilic
    • Journal: Journal of Acute Disease, 2018
    • Citations: 11

 

 

Rajanikant Panda | Neurology | Best Researcher Award

Posted on by ScienceFather

Dr. Rajanikant Panda | Neurology | Best Researcher Award

Postdoctoral researcher at University of California, San Francisco, United States

Rajanikant Panda is a Postdoctoral Research Fellow in Neurology at the University of California, San Francisco (UCSF). He specializes in computational neuroscience, focusing on consciousness. He earned his PhD from the University of Liège, Belgium, and has published over 60 SCI-indexed journal articles, accumulating 1700+ citations with an H-index of 22. Rajanikant has extensive experience in multimodal neuroimaging and computational modeling, using tools like EEG, ECoG, fMRI, and PET to explore brain dynamics across various states of consciousness. He is passionate about applying AI and neuroimaging techniques to improve clinical outcomes for patients with neurological disorders.

Profile

Scholar

🎓 Education

PhD in Medical Science (2017-2022): University of Liège, Belgium – Focused on computational and empirical modeling of altered states of consciousness. M.E. in Applied Electronics (2013-2015): Anna University, India – Conducted research on brain tumor functional network mapping. B.Tech in Biomedical Engineering (2006-2010): Biju Patnaik University of Technology, India – Thesis on EEG signal classification for epileptic seizure detection.

💼 Experience

Postdoctoral Fellow, UCSF, USA (2023–Present): Studying brain dynamics in acute comatose patients. Postdoctoral Fellow, University of Liège, Belgium (2022-2023): Researched virtual reality hypnosis and chronic disorders of consciousness. Junior Scientific Officer, NIMHANS, India (2013-2017): Focused on brain connectivity in neurological patients using EEG-fMRI. Junior Research Fellow, NIMHANS, India (2011-2013): Developed simultaneous EEG-fMRI data acquisition protocols. Biomedical Engineer, Human Kariger Pvt. Ltd, India (2010-2011): Provided technical support for neurofeedback systems.

🏆 Awards and Honors

F.R.S.-FNRS Aspirant Grant for PhD research at University of Liège. DST Travel Grant to present research at an international conference, USA (2012). Guest Editor for journals like Brain Connectivity and Frontiers Psychology – Consciousness Research. Best Paper Awards at international conferences on neuroscience and consciousness.

🔬 Research Focus

Characterizing brain dynamics across consciousness spectrums (meditation, hypnosis, coma). Leveraging computational tools like brain connectivity, network theory, and information theory. Developing multimodal neuroimaging techniques (EEG, ECoG, fMRI, PET). Enhancing neurocritical care through AI-based diagnostics and therapeutic predictions. Investigating mechanisms underlying consciousness in disorders of consciousness and dying patients.

Conclusion

Dr. Panda’s unparalleled expertise, impactful contributions, and commitment to advancing neuroscience make him a deserving recipient of the Best Researcher Award. His work not only pushes the boundaries of scientific knowledge but also offers transformative clinical insights, underlining his significant impact on the field.

Publications 📚

 

  • Classification of EEG signal using wavelet transform and support vector machine for epileptic seizure detection
    • Year: 2010
    • Authors: R Panda, PS Khobragade, PD Jambhule, SN Jengthe, PR Pal, TK Gandhi

 

  • Preservation of brain activity in unresponsive patients identifies MCS star
    • Year: 2021
    • Authors: A Thibaut, R Panda, J Annen, LRD Sanz, L Naccache, C Martial, …

 

  • Quantifying arousal and awareness in altered states of consciousness using interpretable deep learning
    • Year: 2022
    • Authors: M Lee, LRD Sanz, A Barra, A Wolff, JO Nieminen, M Boly, M Rosanova, …

 

  • Decreased integration of EEG source-space networks in disorders of consciousness
    • Year: 2019
    • Authors: J Rizkallah, J Annen, J Modolo, O Gosseries, P Benquet, S Mortaheb, …

 

  • Role of altered cerebello-thalamo-cortical network in the neurobiology of essential tremor
    • Year: 2017
    • Authors: A Lenka, KS Bhalsing, R Panda, K Jhunjhunwala, RM Naduthota, J Saini, …

 

  • Temporal dynamics of the default mode network characterize meditation-induced alterations in consciousness
    • Year: 2016
    • Authors: R Panda, RD Bharath, N Upadhyay, S Mangalore, S Chennu, SL Rao

 

  • Loss of consciousness reduces the stability of brain hubs and the heterogeneity of brain dynamics
    • Year: 2021
    • Authors: A López-González, R Panda, A Ponce-Alvarez, G Zamora-López, …

 

  • Recovery of resting brain connectivity ensuing mild traumatic brain injury
    • Year: 2015
    • Authors: RD Bharath, A Munivenkatappa, S Gohel, R Panda, J Saini, J Rajeswaran, …

 

  • Perturbations in dynamical models of whole-brain activity dissociate between the level and stability of consciousness
    • Year: 2021
    • Authors: Y Sanz Perl, C Pallavicini, I Pérez Ipiña, A Demertzi, V Bonhomme, …

 

  • Machine learning detects EEG microstate alterations in patients living with temporal lobe epilepsy
    • Year: 2018
    • Authors: SS Rajagopalan, S Bhardwaj, R Panda, VR Reddam, C Ganne, …

 

 

Dilshod Mamadaliev | Neurosurgery | Best Researcher Award

Posted on by ScienceFather

Dr. Dilshod Mamadaliev| Neurosurgery |Best Researcher Award 

Dr at Republican Scientific-Practical Medical Center of Neurosurgery,  Uzbekistan

Dr. Dilshod Mamadaliev is a dedicated neurosurgeon from Uzbekistan, committed to enhancing access to professional medical care for all. With a strong passion for making a positive impact in healthcare, he combines his medical expertise with a focus on equal opportunities for treatment. Dr. Mamadaliev’s clinical experience spans various areas of neurosurgery, including skull-based and neurovascular surgeries, as well as neuropathology. He actively participates in professional organizations, contributing to advancements in neurosurgery within his region.

Profile

Scholar

🎓 Education

Dr. Mamadaliev completed his Bachelor’s degree in General Medicine at Tashkent Medical Academy in June 2011, followed by a Master’s degree in General Neurosurgery in July 2015. His education laid a strong foundation in medical science and surgical techniques. He furthered his training as a Resident Fellow at the Republican Scientific Center of Neurosurgery from 2012 to 2015. He has also gained international exposure through clinical fellowships at Fujita Health University, Tübingen University Clinic, and Nagoya University School of Medicine, honing his skills in advanced neurosurgical techniques.

💼 Experience

Since 2015, Dr. Mamadaliev has been practicing as a neurosurgeon at the Republican Scientific-Practical Center of Neurosurgery, specializing in skull-based neurosurgery. He also serves as a neurosurgeon in the Neuro-traumatology Department at Republican Clinical Hospital #1 in Tashkent, a role he has held since 2019. His clinical experience includes performing complex surgical procedures, collaborating with multidisciplinary teams, and contributing to patient care. Dr. Mamadaliev’s involvement in various hospitals has provided him with a broad spectrum of practical skills in neurosurgery and patient management.

🏆 Awards & Honors

Dr. Mamadaliev has received several accolades throughout his career, including the Best Oral Presentation Award at the Tokyo Conference on “21st Annual Japan Neurosurgical Emergency Conference” in 2016 for his work on aneurysm surgery. He has been recognized for his presentations at international conferences, such as the 1st Congress of Neurological Surgeons of Uzbekistan and the 10th Asian Congress of Neurological Surgeons. His commitment to advancing neurosurgery has also earned him certificates of attendance at prestigious international courses, reflecting his dedication to ongoing education and professional development.

🔬 Research Focus

Dr. Mamadaliev’s research interests lie in the fields of general neurosurgery, skull-based surgery, and neurovascular surgery. He focuses on developing innovative techniques to improve surgical outcomes and minimize complications during neurosurgical procedures. His research contributions include presenting findings on advanced surgical methods and participating in workshops aimed at enhancing the skills of neurosurgeons. Through his work, he aims to foster safer and more effective approaches in neurosurgery, ultimately benefiting patient care and treatment options within the field.

Publications Top Notes

  • The Importance of Measuring Mamillopontine Distance as a Diagnostic Criterion of Hydrocephalus Degrees
    Authors: G Kariev, U Asadullaev, T Duschanov, S Rasulov, D Mamadaliev, …
    Year: 2019
    Journal: Asian Journal of Neurosurgery, 14(01), 166-171
    Citations: 8

 

  • Computational Fluid Dynamics Analysis and Correlation with Intraoperative Aneurysm Features
    Authors: A Feletti, X Wang, S Talari, T Mewada, D Mamadaliev, R Tanaka, …
    Year: 2018
    Journal: Trends in the Management of Cerebrovascular Diseases, 3-9
    Citations: 8

 

  • Unilateral Fenestrated A1 Segment of Anterior Cerebral Artery Multiple Aneurysms: Case Reports and Literature Review
    Authors: D Mamadaliev, Y Kato, S Talari, T Mewada, Y Yamada, Y Kei, T Kawase
    Year: 2019
    Journal: Asian Journal of Neurosurgery, 14(03), 957-960
    Citations: 6

 

  • Neurovascular Surgery
    Authors: J July, EJ Wahjoepramono
    Year: 2019
    Publisher: Springer Nature
    Citations: 4

 

  • Neurovascular Surgery: Surgical Approaches for Neurovascular Diseases
    Authors: J July, EJ Wahjoepramono
    Year: 2019
    Publisher: Springer Nature
    Citations: 4

 

  • Awake Craniotomy for Gliomas in the Non-Dominant Right Hemisphere: A Comprehensive Review
    Authors: DM Mamadaliev, R Saito, K Motomura, F Ohka, G Scalia, GE Umana, …
    Year: 2024
    Journal: Cancers, 16(6), 1161
    Citations: 3

 

  • Simplifying the Technique of Awake Brain Surgery in a Condition of Less Equipped Neurosurgical Institution in Uzbekistan
    Authors: DM Mamadaliev, GM Kariev, UM Asadullaev, JB Yakubov, KS Zokirov, …
    Year: 2023
    Journal: Asian Journal of Neurosurgery, 17
    Citations: 3

 

  • Moyamoya Disease, Basic Concepts of Diagnostics, and Treatment
    Authors: D Mamadaliev, A Feletti, T Mewada, K Yamashiro, Y Yamada, T Kawase, …
    Year: 2019
    Book Chapter: Neurovascular Surgery: Surgical Approaches for Neurovascular Diseases, 223-232
    Citations: 3

 

  • Interhemispheric Approach
    Authors: A Feletti, D Mamadaliev, T Mewada, K Yamashiro, Y Yamada, T Kawase, …
    Year: 2019
    Book Chapter: Neurovascular Surgery: Surgical Approaches for Neurovascular Diseases, 29-33
    Citations: 1